Campbell & Co Investment Adviser’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
WA
CAM
CCA
SIMG
GCM
TCM
Campbell & Co Investment Adviser's RGEN Position: Q2 2026 in Review
Campbell & Co Investment Adviser sold out of Repligen (RGEN) in Q2 2026, closing a stake of 46,674 shares — an estimated $5.5M sold.
Campbell & Co Investment Adviser first reported a position in RGEN in Q4 2014 and held it in 12 quarters. The position peaked at $5.5M in Q1 2026. 213 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Campbell & Co Investment Adviser reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 46,674 Repligen shares in Q2 2026, an estimated $5.5M.
- Campbell & Co Investment Adviser first reported a position in Repligen in Q4 2014 and held it in 12 quarters.
- Campbell & Co Investment Adviser's Repligen position peaked at $5.5M in Q1 2026.
- 213 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.